drugset / Trial / NCT00213915

L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function

NCT00213915

Phase 4 Completed 30 enrolled University Hospital, Strasbourg, France
RandomizedParallel-groupDouble-blindTreatment

Summary

* exercise capacities are still altered after heart transplantation partly due to peripheral endothelial dysfunction * cyclosporin-induced renal dysfunction may be due to renal endothelial dysfunction and can be reversed in an animal model by L-arginine supplementation * to determine the potential beneficial effect of L-arginine supplementation on exercise capacity and renal function of heart transplant recipients

Timeline

Start
2004-02
Primary completion
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 12 g Oral

Indications

No indication recorded.